AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 79(3), 2008, pp. 463-470
Copyright © 2008 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Almeida, D. M.
Right arrow Articles by Tambourgi, D. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Almeida, D. M.
Right arrow Articles by Tambourgi, D. V.
Related Collections
Right arrow Venomous creatures

A New Anti-loxoscelic Serum Produced Against Recombinant Sphingomyelinase D: Results of Preclinical Trials

Daniel Manzoni de Almeida, Matheus de F. Fernandes-Pedrosa, Rute M. Gonçalves de Andrade, José Roberto Marcelino, Hisako Gondo-Higashi, Inácio de L. M. Junqueira de Azevedo, Paulo Lee Ho, Carmen van den Berg, AND Denise V. Tambourgi*
Laboratório de Imunoquímica, Instituto Butantan, São Paulo, Brazil; Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Norte, Natal, Brazil; Divisão Bioindustrial e Centro de Biotecnologia, Instituto Butantan, Natal, Brazil; Cardiff University, Wales College of Medicine, Cardiff, United Kingdom

Envenomation by Loxosceles species (brown spider) can lead to local dermonecrosis and to serious systemic effects. The main toxic component in the venom of these spiders is sphingomyelinase D (SMase D) and various isoforms of this toxin are present in Loxosceles venoms. We have produced a new anti-loxoscelic serum by immunizing horses with recombinant SMase D. In the present study, we compared the neutralization efficacy of the new anti-loxoscelic serum and anti-arachnidic serum (the latter serum is used for therapy for loxoscelism in Brazil) against the toxic effects of venoms from spiders of the genus Loxosceles. Neutralization tests showed that anti-SMase D serum has a higher activity against toxic effects of L. intermedia and L. laeta venoms and similar or slightly weaker activity against toxic effects of L. gaucho than that of Arachnidic serum. These results demonstrate that recombinant SMase D can replace venom for anti-venom production and therapy.


Received June 3, 2008. Accepted for publication June 11, 2008.

Financial support: This study was supported by the Fundação de Amparo à Pesquisa do Estado de São Paulo, the Conselho Nacional de Desenvolvimento Científico e Tecnológico, and the Butantan Foundation.

* Address correspondence to Denise V. Tambourgi, Laboratório de Imunoquímica, Instituto Butantan, Av. Prof. Vital Brazil, 1500, CEP 05503-900, São Paulo, São Paulo, Brazil. E-mail: dvtambourgi{at}butantan.gov.br

Authors’ addresses: Daniel Manzoni de Almeida, Rute M. Gonçalves de Andrade, and Denise V. Tambourgi, Laboratório de Imunoquímica, Instituto Butantan, Av. Prof. Vital Brazil, 1500, CEP 05503-900, São Paulo, São Paulo, Brazil, E-mails: daniel{at}butantan.gov.br, rutemgdeandrade{at}butantan.gov.br, and dvtambourgi{at}butantan.gov.br. Matheus de F. Fernandes-Pedrosa, Laboratório de Imunoquímica, Instituto Butantan, Av. Prof. Vital Brazil, 1500, CEP 05503-900, São Paulo, São Paulo, Brazil and Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil, E-mail: mpedrosa{at}ufrnet.br. José Roberto Marcelino and Hisako Gondo-Higashi, Di-visão Bioindustrial, Av. Prof. Vital Brazil, 1500, CEP 05503-900, São Paulo, São Paulo, Brazil, E-mails: marcelino{at}butantan.gov.br and hisa{at}butantan.gov.br. Inácio de L. M. Junqueira de Azevedo and Paulo Lee Ho, Centro de Biotecnologia, Av. Prof. Vital Brazil, 1500, CEP 05503-900, São Paulo, São Paulo, Brazil, E-mails: ijuncaze{at}butantan.gov.br and hoplee{at}butantan.gov.br. Carmen van den Berg, Cardiff University, Wales College of Medicine, Cardiff CF10 3XQ, United Kingdom, E-mail: vandenbergcw{at}yahoo.com.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society of Tropical Medicine and Hygiene.